Tenet Healthcare price target raised to $104 from $95 at UBS

UBS analyst Andrew Mok raised the firm’s price target on Tenet Healthcare to $104 from $95 and keeps a Buy rating on the shares. Tenet delivered on high expectations, managed contract labor costs well, and is still most likely to outperform numbers in the back-half of the year, the analyst tells investors in a research note.